These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22925902)

  • 21. The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.
    Verma M
    Adv Exp Med Biol; 2015; 867():59-80. PubMed ID: 26530360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic biomarkers.
    Chan TA; Baylin SB
    Curr Top Microbiol Immunol; 2012; 355():189-216. PubMed ID: 21818705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaco-epigenomics: On the Road of Translation Medicine.
    López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
    Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor purity and differential methylation in cancer epigenomics.
    Wang F; Zhang N; Wang J; Wu H; Zheng X
    Brief Funct Genomics; 2016 Nov; 15(6):408-419. PubMed ID: 27199459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.
    Verma M; Seminara D; Arena FJ; John C; Iwamoto K; Hartmuller V
    Mol Diagn Ther; 2006; 10(1):1-15. PubMed ID: 16646573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.
    Zhang J; Huang K
    BMC Genomics; 2017 Jan; 18(Suppl 1):1045. PubMed ID: 28198667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic biomarkers in cancer epidemiology.
    Verma M
    Methods Mol Biol; 2012; 863():467-80. PubMed ID: 22359311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma.
    Cao M; Zhang C; Zhou L
    Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
    Jankowska AM; Millward CL; Caldwell CW
    Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.
    Andersen GB; Tost J
    Methods Mol Biol; 2018; 1708():3-30. PubMed ID: 29224136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compendium of aberrant DNA methylation and histone modifications in cancer.
    Hattori N; Ushijima T
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of genome-wide 5-hydroxymethylcytosine studies in cancer research.
    Thomson JP; Meehan RR
    Epigenomics; 2017 Jan; 9(1):77-91. PubMed ID: 27936926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. It's all in the combination: decoding the epigenome for cancer research and diagnostics.
    Furth N; Shema E
    Curr Opin Genet Dev; 2022 Apr; 73():101899. PubMed ID: 35091256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenomic technologies for precision oncology.
    Weichenhan D; Lipka DB; Lutsik P; Goyal A; Plass C
    Semin Cancer Biol; 2022 Sep; 84():60-68. PubMed ID: 32822861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
    Yokoi K; Yamashita K; Watanabe M
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation biomarkers and their utility for solid cancer diagnostics.
    Heichman KA; Warren JD
    Clin Chem Lab Med; 2012 Oct; 50(10):1707-21. PubMed ID: 23089699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.